Dosage Form: injection
Disclaimer: This homeopathic product has not been evaluated by the Food and Drug Administration for safety or efficacy. FDA is not aware of scientific evidence to support homeopathy as effective.
INDICATION AND USAGE
Traumeel® Injection Solution is an anti-inflammatory, analgesic, anti-edematous, anti-exudative combination formulation of 12 botanical ingredients, 1 mineral substance and 1 animal derived substance. Traumeel® Injection Solution is officially classified as a homeopathic combination drug.
Arnica montana. radix (Mountain arnica), Calendula officinalis (Marigold), Hamamelis virginina (Witch hazel), Millefolium (Milfoil), Belladonna (Deadly nightshade), Aconitum napellus (Monkshood), Chamomilla (Chamomile), Symphytum officinale (Comfrey), Bellis perennis (Daisy), Echinacea (Narrow-leaf coneflower), Echinacea purpurea (Purple coneflower), Hypericum perforatum (St. John's Wort)
Mercurius solubilis (Hahnemann's soluble mercury)
Animal derived ingredient:
Hepar sulphuris calcareum (calcium sulfide-made from oyster shells)
Traumeel Dosage and Administration
The dosage schedule listed below can be used as a general guide for the administration of Traumeel® Injection Solution. Traumeel® Injection Solution shows individual differences in clinical response. Therefore, the dosage for each patient should be individualized according to the patient's response therapy. For best results, treatment with Traumeel® Injection Solution should be initiated immediately following injury or at the first signs of symptoms. Traumeel® Injection Solution may be administered until symptoms disappear.
Adults and children 7 years and older: In acute disorders, 1 ampule per day, otherwise 1 ampule, 1 to 3 times per week IM/SC/IV/ID or periarticular. Children ages 2 to 6 receive 1/2 the adult dosage. Discard unused solution.
Traumeel® Injection Solution may be administered intravenously, intramuscularly, subcutaneously, or intradermally. Traumeel® Injection Solution is indicated for intra-articular use under sterile conditions. If coadministration with local anesthetic is desired, Traumeel® Injection Solution may be mixed in a 1:1 ratio with 1% or 2% lidocaine hydrochloride. Similar local anesthetics may also be used. the required dose of Traumeel® Injection Solution is first withdrawn from the ampule into the syringe, and the syringe is then shaken briefly. Normally about 0.5 to 1.0 milliliters of each drug is withdrawn into the syringe. Traumeel® Injection Solution should be administered using a narrow gauge needle (e.g. 22 to 30 gauge). Note: Parental drug products like Traumeel® Injection Solution should be inspected visually for particulate matter and discoloration prior to administration when ever solution and container permit. Traumeel® Injection Solution is a clear, colorless solution. Discolored solutions should be discarded.
ContraindicationsTraumeel® Injection Solution is contraindicated in patients with known hypersensitivity to Traumeel® Injection Solution or any of its ingredients.
Warnings and Precautions
If new syptoms occur, or if redness, pain or swelling at the puncture site persists, the patient should be carefully re-evaluated because these could be signs of a serious condition.
Pregnancy Category C. Animal reproduction studies have not been conducted with this drug. It is also not known whether this drug can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. This drug should be given to a pregnant woman only if clearly needed.
In rare cases, patients with hypersensitivity to botanicals of the Compositae family may experience an allergic reaction after the administration of Traumeel® Injection Solution. Traumeel® Injection Solution ingredients of the Compositae family are: Arnica montana, radix (mountain arnica), Calendula officinalis (marigold), Milefolium (milfoil), Chamomilla (chamomile), Bellis perennis (daisy), Echinacea (narrow-leaf coneflower), Echinacea purpurea (purple coneflower).
Due to the low concentration of active ingredients in homeopathic preparations such as Traumeel® Injection Solution, adverse reactions following overdosage are extremely unlikely. However care must be taken not to exceed the recommended dosage.
Traumeel - Clinical Pharmacology
The exact mechanism of action of Traumeel® Injection Solution is not fully understood. Various cellular and biochemical pathways appear to be modulated by the product ingredients. The mechanism or action of Traumeel® Injection Solution does not appear to be the result of cyclooxygenase or lipoxygenase enzyme inhibition, as is the case with non-steroidal anti-inflammatory drugs (NSAIDS). Traumeel® Injection Solution does not inhibit the arachidonic acid pathway of prostaglandin synthesis. Instead, the mechanism of action of Traumeel® Injection Solution appears to be the result of modulation of the release of oxygen radicals from activated neutrophils, and inhibition of the release of inflammatory mediators (possibly interleukin-1 from activated macrophages) and neuropepetides.
n-vitro studies show that the ingredients of Traumeel® Injection Solution are non-cytotoxic to granulocytes, lymphocytes, platelets, and endothelia, which indicates that the defensive functions of these cells are preserved during treatment with Traumeel® Injection Solution.
The anti-inflammatory, analgesic, anti-edematous, and anti exudative effects of Traumeel® Injection Solution have been demonstrated in clinical trials as well as in-vivo experimental models including the carrageenin-induced edema test and the adjuvant arthritis test.
Injections: 2.2ml ampule
PRINCIPAL DISPLAY PANEL
arnica montana root and atropa belladonna and calendula officinalis flowering top and matricaria recutita and achillea millefolium and calcium sulfide and comfrey root and aconitum napellus and bellis perennis and mercurius solubilis and hypericum perforatum and echinacea and echinacea purpurea and hamamelis virginiana leaf injection
|Labeler - Hameln Pharma GmbH (315869123)|